‘Colloidal silver’ (ionic silver solution), though certainly of use for surface infections, has limitations for the treatment of internal infections. The human body is often imagined as something like a bathtub of water: if you drop a substance into it, it will homogeneously spread out and automatically go everywhere. The body has ‘compartments’ and ‘barriers’, at every order of anatomical scale, down to the sub-cellular level. Silver ions, as with molecules of any medication, do not automatically reach a target area of infection.
Cellular binding sites and internal anatomical pathways
For ingested colloidal silver solution or spray, there are millions or billions of molecular binding sites available for the (+)positively charged silver (cat)ions, starting high up in the gastrointestinal (GI) tract, before they can reach an infection. Internal pathways are very complex and long. For illustration, the chances of getting a therapeutic dose of silver ions to a kidney infection might be very small. The silver ions must get through the stomach, where they can bind to the stomach’s hydrochloric acid and be used up, then go through at least part of GI tract, and eventually find their way to the renal (kidney supplying) arteries and into the inner compartments of the infected kidney(s). If they are not somehow transported or pass out through the walls of the intestines into the bloodstream, they must further be transported out into the circulatory system via the portal venous system route collecting blood from the intestines back through the liver, then back into the heart, in and out of the lungs, then back into the heart again, and finally into systemic circulation.
Inflammation hinders medication delivery
Localized inflammation of the target tissues can limit the delivery of any medication in general circulation. When inflammatory chemicals are increased in localized areas of infection or injury, they can cause mechanical, obstructing changes inside and around the smallest blood vessels (arterioles). Additionally, these arterioles can also become (chronically) constricted under the control of the smallest motor nerve fibers of the autonomic nervous system, resulting in a reduced amount of any medicine delivered via the bloodstream to those target tissues.
SIS electromedical technology
The operation and effects of the SIS electromedical technology does not depend on blood flow. Operating on the basic physics of electric voltages, electric currents and conductivity, a microorganism-specific low intensity constant direct current (LIDC) is delivered via the shortest possible route, directly to the target infection.
To read about the SIS electromedical technology for infection treatments, please continue to the link below: